Graves' disease hyperthyroidism medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {Graves' disease} {{CMG}},{{AE}}{{MehdiP}} ==Overview== ==Hyperthyroidism Therapy== ===Genreral aspects=== *In a small proportion of patients, spontaneous remission...")
 
No edit summary
Line 13: Line 13:


The following table summarizes the medical therapy and surgical option for treatment.
The following table summarizes the medical therapy and surgical option for treatment.
{| class="wikitable"
!Treatment
!Mechanism
!Route of administration
!Advantages
!Disadvantages
!Special considerations
|-
|Beta-blockers
|Block β-adrenergic receptors;
propranolol may block conversion
of T4 to T3
|Oral; may be administered
intravenously in acute
cases
|Ameliorates sweating, anxiety,
tremulousness,
palpitations, and tachycardia
|
* Does not influence course of disease
* Use cautiously in patients with asthma, CHF
, bradyarrhythmias or Raynaud’s
phenomenon
|
* Use cardioselective beta-blockers,
especially in patients with
COPD
* Use calcium-channel
blockers as alternative
|-
|
|
|
|
|
|
|-
|
|
|
|
|
|
|}


==References==
==References==

Revision as of 18:41, 20 December 2016

{Graves' disease} Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Hyperthyroidism Therapy

Genreral aspects

  • In a small proportion of patients, spontaneous remission occurs.
  • Smoking cessation is one of the main stays of treatment.
  • Antithyroid drugs are the first line treatment in Europe.
  • Ablation therapy either by thyroidectomy or radioactive iodine is more accepted in North America.
  • Each treatment approach has advantages and drawbacks. The patient’s preference, after receiving adequate counseling, remains a critical factor in therapy decisions.

The following table summarizes the medical therapy and surgical option for treatment.

Treatment Mechanism Route of administration Advantages Disadvantages Special considerations
Beta-blockers Block β-adrenergic receptors;

propranolol may block conversion

of T4 to T3

Oral; may be administered

intravenously in acute

cases

Ameliorates sweating, anxiety,

tremulousness,

palpitations, and tachycardia

  • Does not influence course of disease
  • Use cautiously in patients with asthma, CHF

, bradyarrhythmias or Raynaud’s

phenomenon

  • Use cardioselective beta-blockers,

especially in patients with

COPD

  • Use calcium-channel

blockers as alternative

References

Template:WH Template:WS